Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile‐Onset Pompe Disease: A Familial History
Open Access
- 1 January 2023
- journal article
- case report
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2023 (1) , 8470341
Abstract
Background . Lysosomal acid alpha‐glucosidase (GAA) deficiency, also known as Pompe disease, is an autosomal recessive disorder that leads to the accumulation of glycogen in lysosomes and cytoplasm, resulting in tissue destruction. Infantile‐onset GAA deficiency is characterized by cardiomyopathy and severe generalized hypotonia. Without treatment, most patients die within the first two years of life. The demonstration of reduced GAA activity, followed by sequencing of the GAA gene, confirms the disease. GAA deficiency is currently treated with enzyme replacement therapy (ERT) with improved clinical outcomes and survival. Case Presentation . We describe the case of DGAA in two siblings, in which the diagnostic time point, treatment, and outcomes were completely different. The girl was diagnosed with DGAA at the age of 6 months during investigations for poor weight gain and excessive sleepiness. The finding of severe cardiomyopathy through EKG and echocardiography led to the suspicion of storage disease, and the GAA deficiency was later confirmed by genetic analysis. The girl died of complications due to the clinical picture before starting ERT. Conversely, her younger brother had the opportunity to receive an early diagnosis and the rapid onset of ERT. He is showing a regression of cardiac hypertrophy. Conclusion . The advent of ERT improved clinical outcomes and survival in infantile‐onset PD. Its impact on cardiac function is still under study, but different reports in the literature have shown encouraging data. Early recognition of DGAA and prompt initiation of ERT is therefore crucial to prevent the progression of the disease and improve the outcomes.Keywords
Funding Information
- Università Degli Studi di Modena e Reggio Emilia
This publication has 17 references indexed in Scilit:
- Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better OutcomesThe Journal of Pediatrics, 2016
- The emerging phenotype of long-term survivors with infantile Pompe diseaseGenetics in Medicine, 2012
- The genotype–phenotype correlation in Pompe diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findingsClinical Neurophysiology, 2011
- Early administration of enzyme replacement therapy for Pompe disease: Short‐term follow‐up resultsJournal of Inherited Metabolic Disease, 2008
- Methods for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meetingMolecular Genetics and Metabolism, 2008
- Cardiomyopathy in Pompe's diseaseEuropean Journal of Internal Medicine, 2008
- Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patientsBrain, 2005
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePediatrics, 2003
- Bradycardia in a Case of Type II Glycogenosis (Pompe’S Disease) Revealing in Early Neonatal PeriodActa Clinica Belgica, 1990